Applied Therapeutics, Inc. (APLT:NASDAQ) closed at $0.103 on February 2, 2026, unchanged on the day. The stock trades 93.1% below its 52-week high of $1.50 and 14.4% above its 52-week low of $0.090. Applied Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 23, 2025, APLT closed higher on 26 days (10%). Its best day was November 17, 2025 (+30.19%) and its worst was November 13, 2025 (-70.33%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 1 time.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.
Find more stocks like APLT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.